Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Spaner

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Leukemia & Lymphoma|October 3, 2018
A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)Christine I Chen, Harminder Paul, Susi Snitzler, et al.
Seminars in Oncology|February 1, 2017
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphomaJoy Mangel, Rena Buckstein, Kevin Imrie, et al.
Seminars in Oncology|February 14, 2002
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphomaJoy Mangel, Rena Buckstein, Kevin Imrie, et al.
The FEBS Journal|November 3, 2018
Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemiaJialei Song, Chunmao Yuan, Jue Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemiaChristine I Chen, P Leif Bergsagel, Harminder Paul, et al.
Leukemia & Lymphoma|October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†Tony Reiman, Kerry J Savage, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2006
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II studyAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Leukemia & Lymphoma|October 3, 2018
A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)Christine I Chen, Harminder Paul, Susi Snitzler, et al.
Seminars in Oncology|February 1, 2017
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphomaJoy Mangel, Rena Buckstein, Kevin Imrie, et al.
Seminars in Oncology|February 14, 2002
Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphomaJoy Mangel, Rena Buckstein, Kevin Imrie, et al.
The FEBS Journal|November 3, 2018
Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemiaJialei Song, Chunmao Yuan, Jue Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Single-agent lenalidomide in the treatment of previously untreated chronic lymphocytic leukemiaChristine I Chen, P Leif Bergsagel, Harminder Paul, et al.
Leukemia & Lymphoma|October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†Tony Reiman, Kerry J Savage, Michael Crump, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2006
Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II studyAsher Chanan-Khan, Kena C Miller, Laurie Musial, et al.
Pageof 3